Showing results (771-780 of 794) with videos related to
Sort By:
Pageof 80
Cell Reports|November 6, 2025
WDFY2 promotes MRN complex formation required for homologous recombination-mediated DNA repairYa-Fei Lu, Huangqi Tang, Longjiang Di, et al.Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Adenosine kinase inhibitors: polar 7-substitutent of pyridopyrimidine derivatives improving their locomotor selectivityGuo Zhu Zheng, Yue Mao, Chih-Hung Lee, et al.Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|July 14, 2022
Dermacentor silvarum, a Medically Important Tick, May Not Be a Competent Vector to Transmit Jingmen Tick VirusLian-Feng Li, Ming-Zhu Zhang, Jin-Guo Zhu, et al.Plos One|January 28, 2014
Generation of "virtual" control groups for single arm prostate cancer adjuvant trialsZhenyu Jia, Michael B Lilly, James A Koziol, et al.Molecular Ecology Resources|February 10, 2018
Draft genome sequence of ramie, Boehmeria nivea (L.) GaudichMing-Bao Luan, Jian-Bo Jian, Ping Chen, et al.Journal of Medicinal Chemistry|June 23, 2007
In vitro structure-activity relationship and in vivo characterization of 1-(aryl)-3-(4-(amino)benzyl)urea transient receptor potential vanilloid 1 antagonistsRichard J Perner, Stanley DiDomenico, John R Koenig, et al.Biochemical and Biophysical Research Communications|April 17, 2017
Role of GPR30 in estrogen-induced prostate epithelial apoptosis and benign prostatic hyperplasiaDeng-Liang Yang, Jia-Wen Xu, Jian-Guo Zhu, et al.Bioorganic & Medicinal Chemistry|April 20, 2006
Structure-activity studies of a novel series of 5,6-fused heteroaromatic ureas as TRPV1 antagonistsIrene Drizin, Arthur Gomtsyan, Erol K Bayburt, et al.Infectious Diseases of Poverty|January 18, 2017
Genetic source tracking of an anthrax outbreak in Shaanxi province, ChinaDong-Li Liu, Jian-Chun Wei, Qiu-Lan Chen, et al.Journal of Medicinal Chemistry|February 4, 2005
Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moietiesArthur Gomtsyan, Erol K Bayburt, Robert G Schmidt, et al.Pageof 80